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There is demand for new, effective, and scalable treatments for depression, and developing 
new forms of cognitive bias modification (CBM) of negative emotional processing biases 
have been suggested as possible interventions to meet this need.  
Methods 
We report two double blind RCTs, in which analogue samples of volunteers with high levels 
of depressive symptoms (BDI-ii > 14) completed a brief course of emotion recognition 
training (a novel form of CBM using faces) or sham training. In study one (N=36), 
participants completed a post training emotion recognition task whilst undergoing fMRI to 
investigate neural correlates of CBM. In study two (N=190), measures of mood were 
assessed post training, and at 2-week and 6-week follow-up.  
Results 
In both studies, CBM resulted in an initial change in emotion recognition bias, which (in study 
two) persisted for 6 weeks after the end of the CBM phase. In study one, CBM resulted in 
increases neural activation to happy faces compared to sad faces, with this effect driven by 
an increase in neural activity in the mPFC and bilateral amygdala. In study two, CBM did not 
lead to a reduction in depressive symptoms on the BDI-ii, or on related measures of mood, 
motivation and persistence, or depressive interpretation bias at either 2 or 6-week follow-
ups.  
Conclusions 
CBM of emotion recognition appears to have effects on neural activity that are similar in 
some respects to those induced by SSRI administration (study one), but we find no evidence 
that this had any later effect on self-reported mood in an analogue sample of non-clinical 





Mood disorders, dominated by major depression, constitute a substantial burden of 
disease. NICE guidelines recommend psychotherapy for mild depression, and cognitive-
behavioural therapy for moderate depression, but these therapies typically require individual 
intervention and therefore, while cost-effective, are expensive. Novel approaches are 
needed to improve treatments for depression, and to prevent relapse.  
Understanding emotional signals is critical to successful social functioning but is 
disrupted in many psychiatric disorders (Cotter, Granger, Backx, Hobbs, Looi & Barnett, 
2018). Negative processing biases may play a role in the onset and maintenance of 
depression. Neurocognitive models suggest that antidepressant medications have early 
effects on emotional processing biases that result in therapeutic benefit only after sufficient 
time has elapsed to allow interaction with others, in which these effects lead to more positive 
social interactions (Warren, Pringle & Harmer, 2015). In support of these models, fMRI 
studies have demonstrated that SSRIs change responses to emotional expressions, and that 
such changes are associated with later improvement in mood (Warren, Pringle and Harmer, 
2015).  
Given the proposed causal role played by emotion processing in depression, biases 
in this area may provide a potential target for behavioural, rather than pharmacological, 
intervention (Penton-Voak, Munafo, & Looi, 2017). We have developed a cognitive bias 
modification (CBM) technique which targets the recognition of facial expression of emotions 
by initially assessing the threshold for detecting one emotion over another in an ambiguous 
expression (e.g., a blend of happiness and sadness), and then providing feedback to shift 
this threshold (e.g., to favour identification of happiness over sadness). Preliminary results 
from adults recruited from the general population indicate robust and generalizable effects 
on emotion perception (Griffiths et al, 2015; Dalili et al, 2016; Penton-Voak et al, 2013). An 
early stage randomised controlled trial (RCT) with participants recruited from the general 
population on the basis of high levels of depressive symptoms on the Beck Depression 
Inventory ii (BDI-ii) also indicated that this intervention may have therapeutic benefit on 
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positive affect which persists for at least two weeks (Penton-Voak et al 2012). This is 
consistent with recent models of the action of antidepressant medication, which suggest that 
drug treatment has early effects on emotional processing bias including the ability to detect 
positive versus negative facial expressions (Harmer, Goodwin et al. 2009, see also Holmes 
et al 2018 ) . Here we investigated the neural correlates of our emotional recognition CBM 
intervention, and the therapeutic potential of this intervention. 
Several studies show that SSRIs have robust effects on emotion processing in the 
amygdala (e.g. Harmer et al, 2006, Godlewska et al, 2012, for review, see Warren, Pringle & 
Harmer, 2015), which plays a key role in detecting the salience of emotional stimuli in the 
environment (Sander, Grafman, & Zalla, 2003; Santos, Mier, Kirsch, & Meyer-Lindenberg, 
2011). The medial network has substantial amygdaloid and limbic connections (Price & 
Drevets, 2010), and altered neural activation is seen in the medial prefrontal cortex in 
individuals suffering from mood disorders, although the pattern of this activation varies 
widely between studies (Lemogne et al., 2009; Yoshimura et al., 2010, Grimm et al., 2009; 
Renner et al., 2015). Similarly, mood related changes in activity are found in the dorsolateral 
prefrontal cortex (dlPFC), a cortical area associated with the control of attention that helps 
regulate the amygdala through indirect inhibitory input (Davidson, 2000; Drevets, 2001). A 
meta-analysis of studies measuring the neural response to affective stimuli showed greater 
response in the amygdala, insula, and dorsal anterior cingulate cortex, and lower response 
in the dorsal striatum and dlPFC to negative stimuli in depressed individuals relative to 
healthy controls (Hamilton et al., 2012). Additionally, a review by Disner et al. (2011) found 
that biased processing of emotional stimuli in depression is associated with greater 
amygdala reactivity, as well as left dlPFC hypoactivity and right dlPFC hyperactivity. 
Study 1 aimed to identify changes in the neural correlates of emotion recognition 
following this novel CBM in an analogue sample of participants with high levels of depressive 
symptoms. We administered five days of the emotion recognition training intervention (or a 
sham training procedure) and then scanned participants using fMRI while performing a face 
perception task that has been previously used to investigate the effects of SSRIs on the 
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processing of emotion facial expressions (Godlewska et al 2012). We hypothesised that 
emotional recognition training would reduce amygdala responses to negative facial 
expressions. We also hypothesised that training would alter activity in the occipital cortex, as 
it is highly connected to the amygdala and is sensitive to attentional change in response to 
emotional stimuli, and the prefrontal cortex, which exerts effects on circuitry implicated in 
pharmacological and psychological treatment for depression. Based on previous findings, we 
established the following areas as our regions of interest (ROIs) for comparing neural 
activation in individuals with low mood in our intervention and control conditions: the bilateral 
amygdala, the mPFC, bilateral dlPFC, and the occipital cortex. 
Study 2 was an early phase RCT, again using an analogue sample of participants 
recruited from the general population on the basis of high levels of depressive symptoms on 
the Beck Depression Inventory ii (BDI-ii), in a direct replication of earlier work (Penton-Voak 
et al 2012), using a larger sample with long-term follow-up. The CBM procedure was 
identical to Study 1 – participants were randomised to receive either five days of the emotion 
recognition training intervention, or a sham training procedure. Participants completed a 
series of assessments of mood and anxiety at 2-week and 6-week follow-up after the end of 
treatment. We hypothesised that participants randomised to the emotion recognition training 
intervention would reduce lower symptoms of depression on the BDI-ii over the previous two 
weeks at 6-week follow-up (our primary outcome). 
 
Methods: Study One 
Participants. We recruited adults from the staff and students at the University of 
Bristol and from the general population who reported depressive symptoms (defined as a 
score of 14 or more on the BDI-ii) (Beck, Steer, & Brown, 1996). Participants were recruited 
via email lists and local advertisements. 
Participants provided informed consent and inclusion/exclusion criteria were 
assessed. Screening consisted of structured clinical interview for DSM-IV: Clinical Interview 
Schedule; CIS-R (Lewis, Pelosi, Araya, & Dunn, 1992), the Altman Self-Rating Mania Scale; 
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ASRM (for bipolar disorder) (Altman, Hedeker, Peterson, & Davis, 1997) and medical 
history. After screening we also collected data on age, sex, ethnicity, alcohol, tobacco and 
caffeine use, previous history of depression (treated and non-treated), intelligence (National 
Adult Reading Test, NART) (Nelson, 1982), number of years of education, social network 
size (SNS), and current and past history of psychiatric treatment. Criteria for exclusion were 
a diagnosis of primary anxiety disorder, psychosis, bipolar disorder, or substance 
dependence (other than nicotine and caffeine) as defined by DSM-IV; current use of an illicit 
drug (except cannabis); being at clinically significant risk for suicidal behaviour; use of 
psychotropic medication in the last 5 weeks prior to the study; major somatic or neurological 
disorders and concurrent medication that could alter emotional processing (including active 
treatment with counseling, cognitive behavioural therapy, or other psychotherapies). 
The study was approved by the Faculty of Science Research Ethics Committee at 
the University of Bristol. On completion of the final study session, participants were 
reimbursed £60 for their time and expenses. 
Study design and intervention. An experimental collaborator at the Bristol 
Randomised Trials Collaboration used minimization to allocate participants to either a 
training procedure designed to promote the perception of happiness over sadness in 
ambiguous emotional expressions, or a control procedure designed to elicit no change in 
perception of emotional expression, in order to ensure the groups were balanced for 
baseline BDI-ii symptoms (grouped according to a score of 14-19, or 20+). Testing was 
double-blind. The CBM intervention consists of three phases. First, in the baseline phase, 
images from a 15 face morph sequence that runs from happy to sad facial expressions are 
presented one at a time, with participants asked to judge whether the face is happy or sad. 
This allows the ‘balance point’ at which participants shift from a ‘happy’ judgement to a ‘sad’ 
judgement to be calculated in terms of the number of images in the 15-face sequence that a 
participant, on average, would classify as happy. We take this as a measure of cognitive 
bias. In the training phase, feedback (correct/incorrect) is used to shift the participant’s 
balance point. In the training condition, the ‘correct’ classification is shifted towards ‘happy’; 
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the two images nearest the balance point that the participant would have previously 
classified as ‘sad’ at baseline are considered ‘happy’ in terms of providing feedback. 
Feedback in the control condition is based directly on baseline performance, and has no 
effect on responses. Sessions last 20 minutes and are fully automated. Methods are 
described in detail elsewhere (Penton-Voak et al 2012, 2013). Participants completed 
computerised training or control procedures once a day over five consecutive days (Monday 
to Friday). fMRI acquisition took place after the completion of training during the last session. 
The study protocol was registered prior to data collection (ISRCTN 50125738). 
Mood Assessment. Mood assessments via questionnaire measures were taken at 
baseline and at the end-of-treatment. End-of-treatment follow-up included a visual analogue 
scale rating of how friendly the participant thought the experimenter was, to ensure that 
there were no differences between treatment conditions that may have affected blinding. The 
questionnaire measures included the Beck Depression Inventory (BDI-ii) (Beck, 1996), the 
Beck Anxiety Inventory (BAI) (Beck, 1988), the Hamilton Rating Scale for Depression (HAM-
D) (Hamilton, 1960), and the Positive and Negative Affect Schedule (PANAS) (Watson, 
Clark, & Tellegen, 1988). 
Functional MRI Behavioural Task. During fMRI scanning, participants completed a 
sex discrimination task involving the rapid presentation of sad, happy, and fearful facial 
expressions. In this task, thirteen 30 sec blocks of a baseline fixation cross were interleaved 
with twelve 30 sec blocks of the emotional task – four blocks of sad, four blocks of happy, 
and four blocks of fear. During each emotional block participants viewed 10 emotional faces 
(5 female) from a standardised image set (Tottenham et al, 2009). Each face was presented 
for 150 ms and participants were asked to report the sex of the face using a keypad. The 
experiment lasted 8.5 min.  
 
Our main contrast of interest was happy>sad. We examined happy>fear and 
happy>sad+fear to explore whether effects generalised to other negative emotions. We also 
examined the three “emotion” > rest contrasts to explore which emotions underpinned any 
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observed effects. Where group differences for emotion contrasts were significant, mean 
percent signal change values were extracted for each participant and compared across 
conditions to characterise the specific effect. Functional MRI data acquisition, pre-processing 
and statistical analysis are described in the Supplementary material.  
Results 
Characteristics of Participants. 36 participants (24 female) aged 18-33 years (M = 
22, SD = 4) were recruited. Due to a randomisation error, there were 19 participants in the 
intervention condition and 17 participants in the control condition. All participants were right-
handed. The characteristics of participants by condition are shown in Table 1. A CONSORT 
diagram is shown in supplementary material, Figure C1. 
 
Insert Table 1 about here. 
 
Behavioural Results. Participants in the intervention condition showed a shift in 
balance point compared to participants in the control condition after 5 sessions, adjusting for 
their session 1 baseline balance point (adjusted mean difference 4.65, 95% CI = 2.95 to 
6.36, P < .001). Mean balance points at baseline and test for intervention and control 
conditions are presented in Figure S1 in supplementary material. A mixed model ANOVA of 
questionnaire score data with a between-subjects factor of training condition (intervention, 
control) and within-subjects factor of time (baseline, follow-up) indicated evidence of main 
effect of time across measures (Fs [1, 33] = 6.66 to 9.59, Ps ≤ .014), reflecting an 
improvement of mood from baseline to follow-up, except for the PANAS positive and 
negative scores (Fs [1, 33] = 2.08 to 3.06, Ps ≥ .089), where the direction of effect was 
consistent with other measures but the statistical evidence weaker. We found no evidence of 
a main effect of training condition in any measures (Fs [1, 33] = 0.07 to 2.72, Ps ≥ .10), or 
any evidence of an interaction between time and training condition across measures (Fs [1, 
33] = 0.24 to 2.68, Ps ≥ .11). Due to a programming error, behavioural data from the sex 
discrimination task were not recorded. 
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Functional MRI Results (regions of interest). Due to a lost imaging data file, we 
analysed the fMRI data of 35 participants (19 intervention, 16 control). Our ROI analyses 
showed evidence of increased activation to the happy>sad contrast in the intervention 
condition relative to the control condition, but only in the left, and not the right, amygdala 
(FWE corrected P < .05, central coordinates 57, 61, 27; see Figure 1, top panel). There were 
no group differences on the happy>sad contrast in the other ROIs (occipital cortex, dlPFC, 
or mPFC).  
 
Insert Figure 1 about here. 
 
Training also increased BOLD activation to happy>fear and happy>sad+fear 
contrasts in the left amygdala. These group differences were driven by increased BOLD 
activation to happy faces in the intervention condition compared to the control condition, with 
higher BOLD activation to the happy>rest contrast in both the left and right amygdala and 
also in the mPFC (see Figure 1, bottom panel). Percent signal change in activation for happy 
faces relative to rest for both the intervention and control conditions in the bilateral amygdala 
and mPFC is shown in Figure 2. There were no group differences for sad>rest, fear>rest, or 
sad>fear, and no evidence for increased activation in any contrasts for the control condition 
relative to the intervention condition. There was no evidence for group differences on any 
contrasts in any other ROIs.  
 
Insert Figure 2 about here. 
 
To further investigate the effect of training in the left and right amygdala between 
conditions for each of our three “emotion” > rest contrasts, we conducted a post-hoc 
repeated measures mixed model ANOVA of percent signal change with a between-subjects 
factor of training condition (intervention or control) and within-subjects factors of hemisphere 
(left or right) and emotion (happy, sad, or fear). We observed evidence of a main effect of 
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training condition (F [1, 33] = 6.53, P = .015), where participants in the intervention condition 
showed greater activation across contrasts relative to the control group. We also found a 
main effect of hemisphere (F [1, 33] = 12.10, P = .001), where participants showed greater 
activation in the right amygdala compared to the left amygdala. We did not find evidence for 
any interactions between factors (P s > .22). Activation for each condition by contrast and 
hemisphere is shown in Figure S2. Independent samples t-tests indicated greater activation 
for the intervention condition relative to the control condition for the happy>rest contrast in 
both the left (mean difference = 2.65, 95% CI 0.044 to 0.334, P = .012) and right (mean 
difference = 2.80, 95% CI 0.069 to 0.436, P = .008) amygdala. We also found evidence of 
greater activation for the intervention condition relative to the control condition for the 
fear>rest contrast in the right amygdala (mean difference = 2.18, 95% CI 0.010 to 0.286, P = 
.036). 
Conclusions: study 1 
Our results suggest that emotion recognition training increases neural activation to 
happy faces compared to sad faces, driven by an increase in neural activity for happy faces. 
We see this increase in activation for this contrast at both the whole brain level (see 
supplementary material) and among our a priori ROIs, specifically the mPFC and bilateral 
amygdala. Our ROI analyses also indicated increased activation for the intervention 
condition relative to the control condition in the left amygdala for the happy>sad, happy>fear, 
happy>sad+fear contrasts. We did not find differences in neural activation between 
conditions for our other contrasts in either our whole brain analyses or in our other ROIs, the 
bilateral dlPFC and the occipital cortex. Participants in the intervention condition did not 
show any clear improvements on measures of depressive symptoms or mood relative to 
controls at end of treatment following emotion recognition training. 
Our finding of clusters of activation for our happy>sad+fear contrast at the whole 
brain level in both the left amygdala and brainstem may be explained by the amygdaloid 
projections underpinning the limbic system. The increase in neural activation for happy 
expressions for the intervention compared to the control condition, resembles changes seen 
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following antidepressant administration. Although effects of SSRIs on amygdala activity in 
response to positive emotional faces have been reported and replicated, they are less robust 
than changes in response to negative facial expressions. This is important mechanistically, 
as anhedonia is characterized by depressed amygdala responses to happy faces (Keedwell 
et al, 2005). 
Increased neural activation to happy faces has been observed following both acute 
and prolonged antidepressant administration, both in healthy and depressed individuals 
(Warren, Pringle & Harmer, 2015). Increased activation to positive emotional information 
following antidepressant treatment has been observed across a large brain network, 
including the amygdala, mPFC, parahippocampal gyrus, and extra-striate cortex. While 
these changes may occur in the absence of any effects on participants’ mood, it has been 
proposed that the early production of a positive bias in emotional processing may be 
predictive of ultimate symptom improvement in depressed patients (see Warren, Pringle, & 
Harmer, 2015 for a review). As we did not find any group differences in activation across our 
contrasts in the bilateral dlPFC and the occipital cortex, we find no evidence that our CBM 
intervention alters attention to emotional expressions, nor does it modify the way these faces 
are perceived by the visual system. Our analyses suggest that emotion recognition training 
may increase the salience of positive emotional expressions indexed by increased neural 
activation in the amygdala in our intervention v control groups.  
 While our results indicate that completing a course of emotion recognition training 
alters neural activation associated with the perception of happy facial expressions, this fMRI 
study was not powered to detect mood outcomes when comparing participants in 
intervention and control conditions. Study 2 addresses this question. 
 
Methods: Study Two 
Participants. We recruited adults who reported depressive symptoms (defined as a 
score of 14 or more on the BDI-ii) from the same population as Study 1.  
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Upon arrival, participants provided informed consent and inclusion/exclusion criteria 
were assessed as in Study One.  
The study was approved by the Faculty of Science Research Ethics Committee at 
the University of Bristol. On completion of the final study session, participants were 
reimbursed £60 for their time and expenses. 
Study design and intervention. As in Study One, participants were allocated to 
condition using minimisation to balance baseline BDI-ii scores by an experimental 
collaborator, and testing was double-blind. The CBM intervention and control procedure 
were the same as in Study One, and participants again completed computerised training or 
control procedures once a day over five consecutive days (Monday to Friday). 
Mood Assessment. Mood assessments via questionnaire measures were taken at 
baseline and at the end-of-treatment.  Questionnaire measures included the BDI-ii, the BAI, 
HAM-D, and the PANAS. 
Other Measures. Social network size was assessed at baseline by asking 
participants to rate the number of close friends  (whom respondents report feeling close to 
and whom they believe they could confide in)they have on a 5-point scale ranging from 0 
(none) to 4 (four or more). Participants repeated this process, rating the number of contacts 
and acquaintances. A contact or acquaintance was defined as a person known by sight or 
known to someone, but not intimately. 
Behavioural assessments (Emotion Recognition Task, Scrambled Sentences Test, 
and the Fishing Game) were taken at the end of treatment, and at 2-week and 6-week 
follow-up. 6-week follow-up also included a visual analogue scale rating of how helpful the 
participant thought the experimenter was, to ensure that there are no differences between 
treatment groups.  
The emotion recognition task was a 45 trial task that was identical to the baseline 
block of the training procedure (i.e. no feedback was given). This was administered to 
determine whether any chance in bias induced by the task persisted to follow-up. The 
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Fishing Game (Pictet et al, 2011)  and Scrambled Sentence Task (Rude et al 2002) are 
described in supplementary material. 
 
Statistical Analysis. We used linear regression to evaluate the effect of training on 
mood at 6-week follow-up. Analyses were conducted with adjustment for the minimization 
factor only, and with additional adjustment for age, sex, ethnicity, previous history of 
treatment for depression, and baseline mood (for analyses of mood variables only). The 
primary outcome was depressive symptoms over the last 2 weeks assessed using the BDI-ii 
at 6-week follow-up. Secondary outcomes included depressive symptoms measured using 
the HAM-D, and positive and negative affect assessed using the PANAS. Subgroup 
analyses were conducted stratified by whether participants meet criteria for clinical 
depression, number of episodes of depression, age at first episode, and whether participants 
had depression with or without anxiety. We also analysed the impact of social network size 
on treatment effect. 
Our preliminary data indicated an effect size of d = 0.43 at 2-week follow-up, 
corresponding to a difference of 3 points on the Positive and Negative Affect Schedule 
(PANAS). This suggested that a sample size of 172 would be required to achieve 80% 
power at an alpha level of 5%. This sample size gave us equivalent power to detect a 
difference of 5 points on the BDI-ii at 6-week follow-up (our primary outcome), which we 
considered would be clinically significant. We aimed to recruit 190 participants to 
accommodate potential attrition. The study protocol was registered prior to data collection 
(ISRCTN17767674) (Adams et al, 2013).  
 
Results: Study two 
Characteristics of Participants. 190 participants (138 female) aged 18 to 39 years 
(M = 21, SD = 4) were recruited. Participant characteristics by are shown in Table 1. A 
CONSORT flow diagram is in supplementary material, figure C2. 
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Primary Outcome. We found no evidence of a reduction in depressive symptoms on 
the BDI-ii at 6-week follow-up (our primary outcome) in the intervention condition compared 
with the control condition in either the unadjusted (mean difference 0.35, 95% CI -2.41 to 
3.10, P = 0.80) or adjusted (mean difference 0.10, 95% CI -2.39 to 2.58, P = 0.94) models. 
Secondary Outcomes. There was no evidence of a difference between the two 
conditions on the BDI-ii at any other time points, or on any other mood measures. These 
results are shown in Table 2. We found no evidence of a difference on the Scrambled 
Sentences Test (unadjusted mean difference 0.48, 95% CI -0.94 to 1.90, P = 0.51; adjusted 
mean difference 0.30, 95% CI -1.12 to 1.72, P = 0.68), or the Fishing Game (unadjusted 
mean difference 0.23, 95% CI -2.24 to 2.70, P = 0.85; adjusted mean difference 0.28, 95% 
CI -2.24 to 2.79, P = 0.83) at 6-week follow-up. However, we did find clear evidence of a 
difference on the Emotion Recognition Task at 6-week follow-up (unadjusted mean 
difference -2.91, 95% CI -3.67 to -2.14, P < 0.001; adjusted mean difference -2.84; 95% CI -
3.63 to -2.06, P < 0.001), indicating that the effect of the intervention on this particular 
cognitive bias persisted beyond the treatment phase.  
 
Insert Table 2 about here. 
 
Planned Sub-Group Analyses.  Subgroup analyses, both unadjusted and adjusted, 
did not indicate any evidence of improved mood in the intervention condition compared to 
the control condition among participants with a diagnosis of clinical depression, number of 
previous episodes of depression, age at first episode among those with a previous episode, 
and among those with high levels of anxiety symptoms. Similarly, social network size had no 
effects on our results. 
Unplanned Exploratory Analyses. Given the lack of an effect of this CBM 
technique on mood  at any time point, we explored whether emotion recognition bias may 
instead serve as a cognitive biomarker for depressed mood, by calculating the correlation 
between pre-training balance point at session 1 and self-reported measures of mood at the 
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same time point. We found evidence of consistent, albeit relatively weak, correlations across 
most measures (BDI-ii: r = -.18, P = .018; HAM-D: r = -.17, P = .021; BAI: r = -.11, P = .12; 
PANAS Positive: r = +.23, P = .001; PANAS Negative: r = -.03, P = .67). At 6 week follow-up, 
these patterns of correlation were still largely present although attenuated (BDI-ii: r = -.08, P 
= .286; HAM-D: r = -.17, P = .035; BAI: r = -.06, P = .44; PANAS Positive: r = +.16, P = .049; 
PANAS Negative: r = +.07, P = .37). These results should be treated with caution given the 
experimental manipulation of balance point. 
Conclusions 
Our results suggest that a novel form of emotion recognition training induces a change in a 
cognitive bias (here, training people to  classify faces as happy under ambiguity) that 
persists for 6 weeks after the end of treatment but does not reduce depressive symptoms on 
the BDI-ii, or on related measures of mood, motivation and persistence, or depressive 
interpretation bias between end of treatment and at 6 week follow up in an analogue sample 
of volunteers with low mood. We found no evidence of specific sub-groups that benefited 
from the intervention. However, we did find evidence that emotion recognition bias may 
serve as a cognitive biomarker for depressed mood (and in particular low positive affect), 
and hence may act as a marker of treatment success.  
 
 These two studies present evidence that a simple, automated CBM task leads to 
training effects that increase amygdala response to happy faces at end of treatment (Study 
1) and have a behavioural effect that persists for at least six weeks (Study 2). There is no 
evidence, however, that this form of cognitive bias modification has any downstream effects 
on either questionnaire measures of mood, or behavioural measures of anhedonia. Given 
the robust nature of the training effects, these findings provide little support of a causal role 
for emotion processing biases, as operationalized here (a bias to recognise happy faces) in 
the onset or maintenance of depression. Other biases have not been assessed and it is 
unknown how cognitive biases may combine in this context (cf. Hirsch, Mathews and Clark, 
2006). A further and clear limitation of the current work is that it employs analogue and not 
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clinical samples, which may not be appropriate to test mood outcomes. These results 
highlight the difficulty of translating interventions to mood outcomes, but provide a biomarker 
model which can be used in future investigations to optimise effects.  
 One possibility is that the emotional training task does not generalize to other 
situations in which any therapeutic effects of a modified bias in responding to happy faces 
may be realized (e.g., social interactions). Although the training effect transfers to other 
faces in an experimental context (e.g., the face task in Study 1, which employs different 
faces to the training task, see also Dalili et al, 2017), there is currently little evidence that this 
bias generalizes to real world encounters with others.  A further RCT employing a modified 
version of the CBM technique reported here aiming to reduce social anxiety in adolescent 
participants also showed weak, but positive results. Although there was no decrease in 
social anxiety, participants in the intervention group showed lower depressive symptoms at 
2-week follow up (Rawdon et al 2018).  
Recent meta-analyses of cognitive bias modification studies (e.g. Cristea et al, 2015) 
indicate inconsistent effects across a range of paradigms aiming to manipulate bias with 
therapeutic effect. Grafton et al (2017) note that this meta-analysis does not discriminate 
between studies that attempt to change a cognitive bias but fail to do so, and those studies 
that successfully modify bias (which, as predicted, have stronger therapeutic effects). Our 
studies show excellent target engagement (responses to faces are changed robustly by this 
CBM procedure) but our mood measures show no change. Additionally, however, Grafton et 
al suggest that mood measures per se may not be the best outcome measures for CBM 
studies, which may serve to reduce emotional vulnerability to further challenges. Our mood 
state outcomes do not investigate this possibility.  However, while a recent study of our CBM 
technique (Peters et al, 2017) with healthy participants showed little evidence of transfer of 
bias modification to a variety of cognitive tasks thought to be impacted by low mood, there 
was weak evidence of transfer to a measure of the impact of stressful events in daily life, 
particularly in those participants with higher baseline anxiety. This is consistent with Grafton 
et al’s reasoning, and may warrant further research. 
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 Alternatively, individual differences in emotion processing may play no causal role in 
the onset or maintenance of depression, and may be a cognitive biomarker of depression 
rather than a therapeutic target. However, this conclusion seems premature given the robust 
behavioural effects on emotion perception and mechanistically interesting neural responses 
we report here, and the large literature on the potential causal role that emotional perception 
plays in depression.  Therefore, further work is justified to examine the potential of this and 
related CBM techniques, perhaps as adjunct therapies to pharmacological or other 
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Table 1. Characteristics of Participants (Studies 1 and 2) 
 
 Study 1  Study 2  
 Intervention (n = 19) Control (n = 17) Intervention (n = 95) Control (n = 95) 
Age 21 (4) 23 (4) 22 (4) 22 (5) 
Sex (female) 13 (68%) 11 (65%) 69 (73%) 69 (73%) 
Ancestry (European)   69 (73%) 64 (67%) 
NART Score 36.47 (6.70) 33.00 (8.73) 38.27 (7.08) 38.26 (6.86) 
Years of Education 15.18 (1.63) 16.53 (2.85) 15.57 (2.43) 15.90 (2.44) 
CISR Score 16.84 (9.34) 15.06 (8.56) 17.71 (9.79 16.78 (11.14) 
ASRM Score 3.42 (2.39) 3.00 (1.66) 2.88 (2.17) 3.00 (2.39) 
BDI-ii Screening 25.21 (8.50) 24.12 (6.75) 25.00 (7.48) 24.55 (8.72) 
BDI-ii Baseline 19.00 (9.10) 18.18 (6.57) 21.05 (9.95) 20.93 (10.13) 
BDI-ii End-of-Treatment 14.37 (5.73) 16.41 (6.96) 17.63 (9.81) 16.98 (10.71) 
BDI-ii Follow-Up (2-week) n/a n/a 16.15 (9.81) 15.73 (10.99) 
BDI-ii Follow-Up (6-week) n/a n/a 13.17 (9.62) 14.01 (10.23) 
BAI Total Baseline 12.95 (8.20) 14.94 (8.54) 14.60 (8.85) 15.86 (10.39) 
BAI Total End-of-Treatment 9.95 (6.70) 12.71 (10.80) 11.30 (7.96) 11.07 (9.05) 
BAI Follow-Up (2-week) n/a n/a 10.83 (9.83) 10.34 (9.60) 
BAI Follow-Up (6-week) n/a n/a 10.33 (9.34) 10.15 (9.05) 
HAM-D Total Baseline 15.05 (5.34) 15.47 (5.43) 13.25 (5.68) 13.41 (6.38) 
HAM-D Total End-of-Treatment 11.74 (5.63) 14.81 (5.12) 9.13 (5.12) 8.90 (5.58) 
HAM-D Follow-Up (2-week) n/a n/a 9.43 (5.76) 9.53 (6.53) 
HAM-D Follow-Up (6-week) n/a n/a 8.08 (5.45) 9.06 (6.06) 
PANAS Positive Score Baseline 17.26 (6.45) 17.59 (4.35) 16.91 (5.33) 18.06 (7.33) 
PANAS Positive Score End-of-Treatment 18.05 (7.15) 19.41 (5.81) 17.81 (6.55) 18.69 (7.36) 
PANAS Positive Follow-Up (2-week) n/a n/a 18.30 (6.78) 19.69 (7.75) 
PANAS Positive Follow-Up (6-week) n/a n/a 19.80 (8.36) 19.99 (7.90) 
PANAS Negative Score Baseline 15.53 (5.38) 16.94 (5.87) 15.84 (5.55) 15.77 (6.06) 
PANAS Negative Score End-of-Treatment 13.53 (3.39) 16.65 (6.08) 15.10 (4.82) 14.54 (5.23) 
PANAS Negative Follow-Up (2-week) n/a n/a 14.76 (5.14) 15.20 (6.15) 
PANAS Negative Follow-Up (6-week) n/a n/a 14.34 (4.47) 14.31 (5.17) 
Experimenter Friendliness 8.73 (1.59) 8.69 (1.52) 8.29 (1.66) 8.48 (1.65) 
 








Table 2. Effects of Emotion Recognition Training on Mood Symptoms in Study 2. 
 
  End of Treatment Follow-Up (2 weeks) Follow-Up (6 weeks) 
  Estimate 95% CI P Estimate 95% CI P Estimate 95% CI P 
BDI-II 
Unadjusted -0.59 -3.33 to 2.15 0.67 -0.26 -3.18 to 2.66 0.86 0.35 -2.41 to 3.10 0.80 
Adjusted -0.50 -2.50 to 1.50 0.62 -0.75 -3.11 to 1.60 0.53 0.10 -2.39 to 2.58 0.94 
BAI 
Unadjusted -0.19 -2.50 to 2.12 0.87 -0.34 -3.08 to 2.39 0.81 -0.15 -2.77 to 2.47 0.91 
Adjusted -1.14 -2.56 to 0.28 0.12 -1.71 -3.96 to 0.53 0.13 -1.10 -3.36 to 1.16 0.34 
HAM-D 
Unadjusted -0.21 -1.72 to 1.30 0.79 0.17 -1.61 to 1.94 0.85 1.02 -0.62 to 2.65 0.22 
Adjusted -0.36 -1.52 to 0.81 0.55 -0.18 -1.56 to 1.20 0.80 0.80 -0.63 to 2.24 0.27 
PANAS Positive 
Unadjusted 0.88 -1.14 to 2.89 0.39 1.35 -0.80 to 3.49 0.22 0.17 -2.20 to 2.54 0.89 
Adjusted 0.20 -1.37 to 1.76 0.81 0.49 -1.31 to 2.28 0.59 -0.44 -2.54 to 1.66 0.68 
PANAS Negative 
Unadjusted -0.52 -1.96 to 0.91 0.47 0.49 -1.17 to 2.14 0.56 -0.02 -1.43 to 1.38 0.97 
Adjusted -0.63 -1.70 to 0.45 0.25 0.36 -0.95 to 1.67 0.59 -0.05 -1.35 to 1.25 0.94 
 
BDI-ii: Beck Depression Inventory; HAM-D Hamilton Rating Scale for Depression; PANAS: Positive and Negative Affect Schedule. Adjusted 
analyses include age, sex, ethnicity, previous history of treatment for depression, and baseline mood score as covariates. 
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